Laura McCreight

844 total citations · 1 hit paper
8 papers, 617 citations indexed

About

Laura McCreight is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Laura McCreight has authored 8 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in Laura McCreight's work include Diabetes Treatment and Management (3 papers), Amino Acid Enzymes and Metabolism (1 paper) and RNA modifications and cancer (1 paper). Laura McCreight is often cited by papers focused on Diabetes Treatment and Management (3 papers), Amino Acid Enzymes and Metabolism (1 paper) and RNA modifications and cancer (1 paper). Laura McCreight collaborates with scholars based in United Kingdom, Qatar and Denmark. Laura McCreight's co-authors include Ewan R. Pearson, Clifford J. Bailey, Tong Wei Yew, Sian Ellard, Kevin Colclough, Jerzy Adamski, Kim Brøsen, Tore Bjerregaard Stage, Flemming Nielsen and Paul Connelly and has published in prestigious journals such as Diabetes, Diabetologia and Diabetic Medicine.

In The Last Decade

Laura McCreight

6 papers receiving 609 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin and the gastrointestinal tract

2016 534 citations Laura McCreight, Clifford J. Bailey et al. Diabetologia profile →

Peers

Countries citing papers authored by Laura McCreight

Since Specialization

Citations

This map shows the geographic impact of Laura McCreight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura McCreight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura McCreight more than expected).

Fields of papers citing papers by Laura McCreight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura McCreight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura McCreight. The network helps show where Laura McCreight may publish in the future.

Co-authorship network of co-authors of Laura McCreight

This figure shows the co-authorship network connecting the top 25 collaborators of Laura McCreight. A scholar is included among the top collaborators of Laura McCreight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura McCreight. Laura McCreight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Hypergonadotropic hypogonadism and chromosomal aberrations: clinical heterogeneity and implications on the health of elderly men, case series 2023 ·BMC Endocrine Disorders ·Tarik Elhadd, Ahmad Majzoub, Charlotte Wilson, Laura McCreight, (unknown), (unknown), Andrew Collier	1
2	1122-P: Physiological Effects of Pioglitazone in Ataxia-Telangiectasia 2019 ·Diabetes ·Laura McCreight, Andrea Mari, Ewan R. Pearson	0
3	1121-P: Metformin Intolerance, Proton Pump Inhibitors, and OCT1 Variation: A Recruit-by-Genotype, Randomised Controlled Trial (ImpOCT) 2019 ·Diabetes ·Laura McCreight, Simona Hapca, Ewan R. Pearson	0
4	Pharmacokinetics of metformin in patients with gastrointestinal intolerance 2018 ·Diabetes Obesity and Metabolism ·Laura McCreight, Tore Bjerregaard Stage, Paul Connelly, Mike Lonergan, Flemming Nielsen, Cornelia Prehn, Jerzy Adamski, Kim Brøsen, Ewan R. Pearson	37
5	Quantitative MRI evaluation of whole abdomen adipose tissue volumes in healthy volunteers—validation of technique and implications for clinical studies 2018 ·British Journal of Radiology ·(unknown), (unknown), Laura McCreight, Ewan R. Pearson, (unknown), Stephen J. Gandy	7
6	Metformin and the gastrointestinal tract breakdown → 2016 ·Diabetologia ·Laura McCreight, Clifford J. Bailey, Ewan R. Pearson	534
7	tRNA methyltransferase homologue gene TRMT10A mutation in young adult‐onset diabetes with intellectual disability, microcephaly and epilepsy 2015 ·Diabetic Medicine ·Tong Wei Yew, Laura McCreight, Kevin Colclough, Sian Ellard, Ewan R. Pearson	36
8	How safe are DPP‐4 inhibitors? 2013 ·Practical Diabetes ·Laura McCreight, Miles Fisher	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact